BB BIOTECH AG - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Agios Pharmaceuticals, Inc. (AGIO)

Filing Manager
BB BIOTECH AG
Reporting Manager
BB Biotech AG
Security
Agios Pharmaceuticals, Inc. Common Stock
Symbol
AGIO
Shares outstanding
56.7M shares
Disclosed Ownership
3.52M shares
Ownership
6.2%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 02:35 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BB Biotech AG 6.2% 3.52M 0 3.52M /s/ Martin Gubler Martin Gubler/Signatory Authority
Biotech Target N.V. 6.2% 3.52M 0 3.52M /s/ Jan Bootsma Jan Bootsma/Signatory Authority